CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy
Authors: | Bai, X., Guo, Z. Q., Zhang, Y. P., Fan, Z. Z., Liu, L. J., Liu, L., Long, L. L., Ma, S. C., Wang, J., Fang, Y., Tang, X. R., Zeng, Y. J., Pan, X., Wu, D. H., & Dong, Z. Y. |
---|---|
PubYear: | 2023 |
Journal: | Nature communications |